Open Journal of Medicinal Chemistry
Vol.5 No.4(2015), Paper ID 62231, 10
pages
DOI:10.4236/ojmc.2015.54007
In Silico Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors
Gabriela Souza Fernandes, Michelle Bueno de Moura Pereira, Ana Cláudia Barbosa Marinho, Brisa Machado, Ana Carla Moreira, Matheus Puggina de Freitas, Karen Luise Lang, João Eustáquio Antunes
Department of Medicine, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Medicine, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Medicine, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Pharmacy, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Pharmacy, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Chemistry, Federal University of Lavras, Lavras, Brazil
Department of Pharmacy, Federal University of Juiz de Fora, Governador Valadares, Brazil
Department of Pharmacy, Federal University of Juiz de Fora, Governador Valadares, Brazil
Copyright © 2015 Gabriela Souza Fernandes, Michelle Bueno de Moura Pereira, Ana Cláudia Barbosa Marinho, Brisa Machado, Ana Carla Moreira, Matheus Puggina de Freitas, Karen Luise Lang, João Eustáquio Antunes et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Fernandes, G. , Pereira, M. , Marinho, A. , Machado, B. , Moreira, A. , Freitas, M. , Lang, K. and Antunes, J. (2015) In
Silico Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors.
Open Journal of Medicinal Chemistry,
5, 106-115. doi:
10.4236/ojmc.2015.54007.